A combined-cross analysis reveals genes with drug-specific and background-dependent effects on drug sensitivity in Saccharomyces cerevisiae

Genetics

Volumn 183, Issue 3, 2009, Pages 1141-1151

  Kim, Hyun Seok ^a,c   Fay, Justin C ^a,b  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATHIONINE BETA SYNTHASE;

ARTICLE; BACTERIAL STRAIN; CROSS LINKING; DRUG EFFECT; DRUG RESPONSE; DRUG SENSITIVITY; DRUG SPECIFICITY; GENE INTERACTION; GENE LOCUS; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENETIC LINKAGE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS MAPPING; SACCHAROMYCES CEREVISIAE; SINGLE NUCLEOTIDE POLYMORPHISM;

AQUAPORINS; CHROMOSOME MAPPING; CHROMOSOMES, FUNGAL; CROSSES, GENETIC; CYSTATHIONINE BETA-SYNTHASE; DRUG RESISTANCE, FUNGAL; EPISTASIS, GENETIC; GENES, FUNGAL; GENOTYPE; MODELS, GENETIC; PHENOTYPE; QUANTITATIVE TRAIT LOCI; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; XENOBIOTICS;

SACCHAROMYCES CEREVISIAE;

EID: 72449193105     PISSN: 00166731     EISSN: 00166731     Source Type: Journal    
DOI: 10.1534/genetics.109.108068     Document Type: Article

References (71)

1. BAETZ, K., L. MCHARDY, K. GABLE, T. TARLING, D. REBERIOUX et al., 2004 Yeast genome-wide drug-induced haploinsufficiency screen to determine drug mode of action. Proc. Natl. Acad. Sci. USA 101: 4525-4530.
2. BALZI, E., and A. GOFFEAU, 1995 Yeast multidrug resistance: the PDR network. J. Bioenerg. Biomembr. 27: 71-76.
3. BARRETO, L., A. GARCERÁ, K. JANSSON, P. SUNNERHAGEN and E. HERRERO, 2006 A peroxisomal glutathione transferase of Saccharomyces cerevisiae is functionally related to sulfur amino acid metabolism. Eukaryot. Cell 5: 1748-1759.
4. BEITZ, E., B. WU, L. M. HOLM, J. E. SCHULTZ and T. ZEUTHEN, 2006 Point mutations in the aromatic/arginine region in aquaporin 1 allow passage of urea, glycerol, ammonia, and protons. Proc. Natl. Acad. Sci. USA 103: 269-274.
5. BEN-ARI, G., D. ZENVIRTH, A. SHERMAN, L. DAVID, M. KLUTSTEIN et al., 2006 Four linked genes participate in controlling sporulation efficiency in budding yeast. PLoS Genet. 2: e195.
6. BLANC, G., A. CHARCOSSET, B. MANGIN, A. GALLAIS and L. MOREAU, 2006 Connected populations for detecting quantitative trait loci and testing for epistasis: an application in maize. Theor. Appl. Genet. 113: 206-224.
7. BLEIBEL, W. K., S. DUAN, R. S. HUANG, E. O. KISTNER, S. J. SHUKLA et al., 2009 Identification of genomic regions contributing to etoposide-induced cytotoxicity. Hum. Genet. 125: 173-180.
8. BONHIVERS, M., J. M. CARBREY, S. J. GOULD and P. AGRE, 1998 Aquaporins in Saccharomyces. Genetic and functional distinctions between laboratory and wild-type strains. J. Biol. Chem. 273: 27565-27572.
9. BREM, R., G. YVERT, R. CLINTON and L. KRUGLYAK, 2002 Genetic dissection of transcriptional regulation in budding yeast. Science 296: 752-755. (Pubitemid 34442007)
10. BREM, R., J. STOREY, J. WHITTLE and L. KRUGLYAK, 2005 Genetic interactions between polymorphisms that affect gene expression in yeast. Nature 436: 701-703. (Pubitemid 41117272)
11. BROMAN, K., H. WU, S. SEN and G. CHURCHILL, 2003 R/qtl: QTL mapping in experimental crosses. Bioinformatics 19: 889-890.
12. CHEVERUD, J. M., T. H. EHRICH, T. HRBEK, J. P. KENNEY, L. S. PLETSCHER et al., 2004 Quantitative trait loci for obesity- and diabetes-related traits and their dietary responses to high-fat feeding in LGXSM recombinant inbred mouse strains. Diabetes 53: 3328-3336.
13. CHOY, E., R. YELENSKY, S. BONAKDAR, R. M. PLENGE, R. SAXENA et al., 2008 Genetic analysis of human traits in vitro: drug response and gene expression in lymphoblastoid cell lines. PLoS Genet. 4: e1000287.
14. DECOTTIGNIES, A., and A. GOFFEAU, 1997 Complete inventory of the yeast ABC proteins. Nat. Genet. 15: 137-145.
15. DEMOGINES, A., E. SMITH, L. KRUGLYAK and E. ALANI, 2008 Identification and dissection of a complex DNA repair sensitivity phenotype in Baker's yeast. PLoS Genet. 4: e1000123.
16. DEUTSCHBAUER, A. M., and R. W. DAVIS, 2005 Quantitative trait loci mapped to single-nucleotide resolution in yeast. Nat. Genet. 37: 1333-1340.
17. DIMITROV, L. N., R. B. BREM, L. KRUGLYAK and D. E. GOTTSCHLING, 2009 Polymorphisms in multiple genes contribute to the spontaneous mitochondrial genome instability of Saccharomyces cerevisiae S288C strains. Genetics 183: 365-383.
18. DOERGE, R. W., and G. A. CHURCHILL, 1996 Permutation tests for multiple loci affecting a quantitative character. Genetics 142: 285-294.
19. DOLAN, M. E., K. G. NEWBOLD, R. NAGASUBRAMANIAN, X. WU, M. J. RATAIN et al., 2004 Heritability and linkage analysis of sensitivity to cisplatin-induced cytotoxicity. Cancer Res. 64: 4353-4356.
20. DUAN, S., W. K. BLEIBEL, R. S. HUANG, S. J. SHUKLA, X. WU et al., 2007 Mapping genes that contribute to daunorubicin-induced cytotoxicity. Cancer Res. 67: 5425-5433. (Pubitemid 46997283)
21. EVANS, W. E., and J. A. JOHNSON, 2001 Pharmacogenomics: the inherited basis for interindividual differences in drug response. Annu. Rev. Genomics Hum. Genet. 2: 9-39.
22. EVANS, W. E., and H. L. MCLEOD, 2003 Pharmacogenomics: drug disposition, drug targets, and side effects. N. Engl. J. Med. 348: 538-549.
23. GERKE, J., K. LORENZ and B. COHEN, 2009 Genetic interactions between transcription factors cause natural variation in yeast. Science 323: 498-501.
24. GIAEVER, G., P. FLAHERTY, J. KUMM, M. PROCTOR, C. NISLOW et al., 2004 Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. Proc. Natl. Acad. Sci. USA 101: 793-798.
25. GOTTESMAN, M., T. FOJO and S. BATES, 2002 Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2: 48-58.
26. GUO, B., D. A. SLEPER, J. SUN, H. T. NGUYEN, P. R. ARELLI et al., 2006 Pooled analysis of data from multiple quantitative trait locus mapping populations. Theor. Appl. Genet. 113: 39-48.
27. HAYES, J. D., J. U. FLANAGAN and I. R. JOWSEY, 2005 Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 45: 51-88.
28. HECK, J. A., J. L. ARGUESO, Z. GEMICI, R. G. REEVES, A. BERNARD et al., 2006 Negative epistasis between natural variants of the Saccharomyces cerevisiae MLH1 and PMS1 genes results in a defect in mismatch repair. Proc. Natl. Acad. Sci. USA 103: 3256-3261.
29. HILLENMEYER, M. E., E. FUNG, J. WILDENHAIN, S. E. PIERCE, S. HOON et al., 2008 The chemical genomic portrait of yeast: uncovering a phenotype for all genes. Science 320: 362-365.
30. HUANG, R. S., S. DUAN, W. K. BLEIBEL, E. O. KISTNER, W. ZHANG et al., 2007 A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity. Proc. Natl. Acad. Sci. USA 104: 9758-9763.
31. INGELMAN-SUNDBERG, M., S. C. SIM, A. GOMEZ and C. RODRIGUEZ- ANTONA, 2007 Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol. Ther. 116: 496-526.
32. JAGODIC, M., and T. OLSSON, 2006 Combined-cross analysis of genome- wide linkage scans for experimental autoimmune encephalomyelitis in rat. Genomics 88: 737-744.
33. JANSEN, R. C., 1993 Interval mapping of multiple quantitative trait loci. Genetics 135: 205-211.
34. KATZ, D. A., and A. BHATHENA, 2009 Overview of pharmacogenetics. Curr. Protoc. Hum. Genet. 60: 9.19.1-9.19.23.
35. KIM, H. S., and J. C. FAY, 2007 Genetic variation in the cysteine biosynthesis pathway causes sensitivity to pharmacological compounds. Proc. Natl. Acad. Sci. USA 104: 19387-19391.
36. KIM, H. S., J. HUH and J. C. FAY, 2009 Dissecting the pleiotropic consequences of a quantitative trait nucleotide. FEMS Yeast Res. 9: 713-722.
37. KNOTT, S. A., and C. S. HALEY, 2000 Multitrait least squares for quantitative trait loci detection. Genetics 156: 899-911. (Pubitemid 30781818)
38. KOEPSELL, H., 2004 Polyspecific organic cation transporters: their functions and interactions with drugs. Trends Pharmacol. Sci. 25: 375-381.
39. KUCHLER, K., and J. THORNER, 1992 Functional expression of human mdr1 in the yeast Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 89: 2302-2306.
40. LAIZÉ, V., R. GOBIN, G. ROUSSELET, C. BADIER, S. HOHMANN et al., 1999 Molecular and functional study of AQY1 from Saccharomyces cerevisiae: role of the C-terminal domain. Biochem. Biophys. Res. Commun. 257: 139-144.
41. LAZAROU, J., B. H. POMERANZ and P. N. COREY, 1998 Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. J. Am. Med. Assoc. 279: 1200-1205.
42. LEE, S., A. M. DUDLEY, D. DRUBIN, P. A. SILVER, N. J. KROGAN et al., 2009 Learning a prior on regulatory potential from eQTL data. PLoS Genet. 5: e1000358.
43. LI, R., M. LYONS, H. WITTENBURG, B. PAIGEN and G. CHURCHILL, 2005 Combining data from multiple inbred line crosses improves the power and resolution of quantitative trait loci mapping. Genetics 169: 1699-1709.
44. LUM, P., C. ARMOUR, S. STEPANIANTS, G. CAVET, M. WOLF et al., 2004 Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell 116: 121-137.
45. MALMANGER, B., M. LAWLER, S. COULOMBE, R. MURRAY, S. COOPER et al., 2006 Further studies on using multiple-cross mapping (MCM) to map quantitative trait loci. Mamm. Genome 17: 1193-1204.
46. MÄNNISTÖ, P. T., and S. KAAKKOLA, 1999 Catechol-O- methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol. Rev. 51: 593-628.
47. MOYE-ROWLEY, W. S., 2005 Retrograde regulation of multidrug resistance in Saccharomyces cerevisiae. Gene 354: 15-21. (Pubitemid 41116676)
48. NILSSON, B. O., 1999 Biological effects of aminoguanidine: an update. Inflamm. Res. 48: 509-515.
49. NOGAMI, S., Y. OHYA and G. YVERT, 2007 Genetic complexity and quantitative trait loci mapping of yeast morphological traits. PLoS Genet. 3: e31.
50. PERLSTEIN, E. O., D. M. RUDERFER, G. RAMACHANDRAN, S. J. HAGGARTY, L. KRUGLYAK et al., 2006 Revealing complex traits with small molecules and naturally recombinant yeast strains. Chem. Biol. 13: 319-327.
51. PERLSTEIN, E. O., D. M. RUDERFER, D. C. ROBERTS, S. L. SCHREIBER and L. KRUGLYAK, 2007 Genetic basis of individual differences in the response to small-molecule drugs in yeast. Nat. Genet. 39: 496-502.
52. SHAH, R. R., 2006 Can pharmacogenetics help rescue drugs withdrawn from the market? Pharmacogenomics 7: 889-908.
53. SHUKLA, S. J., S. DUAN, X. WU, J. A. BADNER, K. KASZA et al., 2009 Whole-genome approach implicates CD44 in cellular resistance to carboplatin. Hum. Genomics 3: 128-142.
54. SIDOUX-WALTER, F., N. PETTERSSON and S. HOHMANN, 2004 The Saccharomyces cerevisiae aquaporin Aqy1 is involved in sporulation. Proc. Natl. Acad. Sci. USA 101: 17422-17427.
55. SINHA, H., B. P. NICHOLSON, L. M. STEINMETZ and J. H. MCCUSKER, 2006 Complex genetic interactions in a quantitative trait locus. PLoS Genet. 2: e13.
56. SINHA, H., L. DAVID, R. C. PASCON, S. CLAUDER-MÜNSTER, S. KRISHNAKUMAR et al., 2008 Sequential elimination ofmajor-effect contributors identifies additional quantitative trait loci conditioning high-temperature growth in yeast. Genetics 180: 1661-1670.
57. SMITH, E. N., and L. KRUGLYAK, 2008 Gene-environment interaction in yeast gene expression. PLoS Biol. 6: e83.
58. STEINMETZ, L. M., H. SINHA, D. R. RICHARDS, J. I. SPIEGELMAN, P. J. OEFNER et al., 2002 Dissecting the architecture of a quantitative trait locus in yeast. Nature 416: 326-330. (Pubitemid 34260247)
59. TADAUCHI, T., T. INADA, K. MATSUMOTO and K. IRIE, 2004 Posttranscriptional regulation of HO expression by the Mkt1-Pbp1 complex. Mol. Cell. Biol. 24: 3670-3681.
60. TANGHE, A., D. P. VAN, F. DUMORTIER, A. TEUNISSEN, S. HOHMANN et al., 2002 Aquaporin expression correlates with freeze tolerance in baker's yeast, and overexpression improves freeze tolerance in industrial strains. Appl. Environ. Microbiol. 68: 5981-5989.
61. TANGHE, A., P. VAN DIJCK, D. COLAVIZZA and J. M. THEVELEIN, 2004 Aquaporin-mediated improvement of freeze tolerance of Saccharomyces cerevisiae is restricted to rapid freezing conditions. Appl. Environ. Microbiol. 70: 3377-3382.
62. WACH, A., A. BRACHAT, R. PÖHLMANN and P. PHILIPPSEN, 1994 New heterologous modules for classical or PCR-based gene disruptions in Saccharomyces cerevisiae. Yeast 10: 1793-1808.
63. WASHTIEN, W., and R. H. ABELES, 1977 Mechanism of inactivation of gamma-cystathionase by the acetylenic substrate analogue propargylglycine. Biochemistry 16: 2485-2491.
64. WATTERS, J. W., A. KRAJA, M. A. MEUCCI, M. A. PROVINCE and H. L. MCLEOD, 2004 Genome-widediscovery of loci influencing chemotherapy cytotoxicity. Proc. Natl. Acad. Sci. USA 101: 11809-11814.
65. WICKNER, R. B., 1980 Plasmids controlled exclusion of the K2 killer double-stranded RNA plasmid of yeast. Cell 21: 217-226.
66. WICKNER, R. B., 1987 MKT1, a nonessential Saccharomyces cerevisiae gene with a temperature-dependent effect on replication of M2 double-stranded RNA. J. Bacteriol. 169: 4941-4945.
67. WIELAND, J., A. M. NITSCHE, J. STRAYLE, H. STEINER and H. K. RUDOLPH, 1995 The PMR2 gene cluster encodes functionally distinct isoforms of a putative Na+ pump in the yeast plasma membrane. EMBO J. 14: 3870-3882.
68. WOLFGER, H., Y. M. MAMNUN and K. KUCHLER, 2001 Fungal ABC proteins: pleiotropic drug resistance, stress response and cellular detoxification. Res. Microbiol. 152: 375-389.
69. WOLFGER, H., Y. M. MAMNUN and K. KUCHLER, 2004 The yeast Pdr15p ATP-binding cassette (ABC) protein is a general stress response factor implicated in cellular detoxification. J. Biol. Chem. 279: 11593-11599.
70. WU, B., and E. BEITZ, 2007 Aquaporins with selectivity for unconventional permeants. Cell. Mol. Life Sci. 64: 2413-2421.
71. ZENG, Z. B., 1993 Theoretical basis for separation of multiple linked gene effects in mapping quantitative trait loci. Proc. Natl. Acad. Sci. USA 90: 10972-10976.